Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jaka Biotech CoBJSE:920165 20 Market Cap is ¥1,777.5 Mil as of Aug. 31, 2026. GuruFocus rates BJSE:920165 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 2,048 Consumer Packaged Goods companies, Jaka Biotech Co ranks better than 63.43% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Jaka Biotech Co's share price for the quarter that ended in Jun. 2026 was ¥0. Jaka Biotech Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 41.0 Mil. Therefore, Jaka Biotech Co's market cap for the quarter that ended in Jun. 2026 was ¥0.0 Mil.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Jaka Biotech Co's Enterprise Value for Today is ¥1,633.0 Mil.
Jaka Biotech Co (BJSE:920165) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Jaka Biotech Co Market Cap Related Terms
Jaka Biotech Co Market Cap Historical Data
* Premium members only.
The historical data trend for Jaka Biotech Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Jaka Biotech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jaka Biotech Co Market Cap vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Jaka Biotech Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Jaka Biotech Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Jaka Biotech Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaka Biotech Co (BJSE:920165) has a Market Cap of ¥1,777.5 Mil as of Aug. 31, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Jaka Biotech Co and its competitors. According to the industry distribution chart, Jaka Biotech Co ranks #749 out of 2048 companies in the Consumer Packaged Goods industry, placing it in the top 36.6%.
Is Jaka Biotech Co's Market Cap too high?
Jaka Biotech Co's current Market Cap is ¥1,777.5 Mil. Based on the distribution chart, Jaka Biotech Co ranks #749 out of 2048 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Jaka Biotech Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Jaka Biotech Co's Market Cap compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Jaka Biotech Co ranks #749 out of 2048 companies for Market Cap. This puts Jaka Biotech Co in the upper half of its industry. The industry median Market Cap is 109.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Consumer Packaged Goods company?
The median Market Cap among Consumer Packaged Goods companies is 109.61, based on 2,048 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Jaka Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median Market Cap is 109.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jaka Biotech Co's current Market Cap is ¥1,777.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaka Biotech Co stock overvalued right now?
Jaka Biotech Co (BJSE:920165) has a current Market Cap of ¥1,777.5 Mil. The current Market Cap is ¥1,777.5 Mil. Jaka Biotech Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Jaka Biotech Co (BJSE:920165), the current Market Cap is ¥1,777.5 Mil as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jaka Biotech Co Ltd is engaged in the research, development, production and sales of cosmetic functional ingredients. Its operations include pharmaceutical manufacturing, testing and inspection services, manufacturing and sales of specialty chemical products, and bio-based materials.
20GF Score
Get the complete analysis for BJSE:920165
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920165 has been successfully added to your 
